The chairman of Bharat Biotech - whose coronavirus vaccine Covaxin was yesterday given 'restricted use in emergency situation in public interest' - hit out today at critics querying the lack of Phase III trial data and others questioning the drug's efficacy.
Recommended Video
Haqikat Kya Hai: Big news ahead of Diwali, Covaxin approved by WHO
Covid: Expert panel recommends emergency use Covaxin for 2-18 age group
Covid Vaccines for children to be available by September: Dr.Randeep Guleria
Aaj Ki Baat: Why rumour was spread on social media that calf serum was used in making of Covaxin vaccine
Top News
Latest News
